Applied Biosystems Helps China Respond to Melamine Contamination in Dairy Products
News Dec 18, 2008
Applied Biosystems, part of Life Technologies Corporation, has announced that the Chinese government and two leading food manufacturers are implementing its mass spectrometry-based technologies for food analysis as part of efforts to identify and contain the spread of melamine in the food supply.
Melamine contamination in dairy products is getting widespread attention following recent media reports of outbreaks in China and other countries. More than 94,000 infants and young children have been treated for health issues related to tainted infant formula and other products. China is responding to this issue with a series of actions that include increased food safety testing.
The Chinese government and industry are taking action to protect a broad range of food products and animal feed, through enhanced testing procedures that require laboratory instrumentation capable of identification of melamine and other contaminants.
“Food safety is one of the most important issues for government agencies and industry around the world,” said Laura Lauman, President of Life Technologies’ mass spectrometry systems division. “AB SCIEX mass spectrometry solutions are playing a critical role in helping China and other countries, including the United States, to ensure the safety of food being produced for consumption inside their borders and abroad.”
Arrow Poison Potential Male Birth ControlNews
Women have many options for oral contraceptives that are safe, effective and reversible, but despite decades of research, men have none. Now, scientists report a rat study that shows they finally have a good lead for a male birth control pill. It's based on ouabain, a plant extract that African warriors and hunters traditionally used as a heart-stopping poison on their arrows.READ MORE
Robust Multiplex Mass Spectrometric Assay for Screening Small-Molecule InhibitorsNews
A new original research article presents a fast, sensitive, and robust methodology for screening small molecule inhibitors against CD73/Ecto-5'-Nucleotidase, a promising target for developing anti-cancer drugs.READ MORE